MDGL financials
Madrigal Pharma (MDGL) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
MDGL income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $958.40M | $902.25M | -$300.10M | -$288.28M | -12.85 |
| 2024 | $180.13M | $173.90M | -$497.88M | -$465.89M | -21.90 |
| 2023 | $0.00 | $0.00 | -$380.50M | -$373.63M | -19.99 |
| 2022 | $0.00 | $0.00 | -$293.57M | -$295.35M | -17.23 |
| 2021 | $0.00 | $0.00 | -$242.48M | -$241.85M | -14.63 |
| 2020 | $0.00 | -$471.00K | -$206.32M | -$202.24M | -13.09 |
- MDGL revenue was $958.40M in fiscal 2025, net income -$288.28M.
Updated 2026-11-03 00:45 UTC